Snowden Capital Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-78,879
Closed -$2.69M 1169
2022
Q3
$2.69M Buy
+78,879
New +$2.92M 0.12% 205

Other funds holding PRVA

Snowden Capital Advisors's PRVA Position: Q4 2022 in Review

Snowden Capital Advisors sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 78,879 shares — an estimated $2.69M sold.

Snowden Capital Advisors first reported a position in PRVA in Q3 2022 and held it in 1 quarter. The position peaked at $2.69M in Q3 2022. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

  • Snowden Capital Advisors reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 78,879 Privia Health shares in Q4 2022, an estimated $2.69M.
  • Snowden Capital Advisors first reported a position in Privia Health in Q3 2022 and held it in 1 quarter.
  • Snowden Capital Advisors's Privia Health position peaked at $2.69M in Q3 2022.
  • 192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on Snowden Capital Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.